A New Standard for Rapid Microbiological Testing
BioSense Technologies has developed a new rapid method for determining the physiological status of cells. The company is using this technology to detect bacteria and other pathogens and determine their susceptibility to therapeutic agents in near-real time. Our goal is to improve the diagnosis and treatment of infectious diseases and prevent the development and spread of antibiotic resistance.